Input 2021.04.07 14:15 | Revision 2021.04.07 14:19
“Medium level compared to the world’s best competitiveness in the domestic digital health industry”
The Korea Health Industry Development Institute’s Health Industry Policy Research Center announced this through a report on the’Digital Health Industry Analysis and Prospect Study’ on the 7th.
The domestic digital health industry’s growth rate over the next five years, considered by domestic experts, is 15.3%. There was a large deviation in the domestic industry growth rate (minimum 4.0% to maximum 50%) by expert, but it was forecasted to be a growth trend. The mobile health sector is forecasted to be higher than the global growth rate.
Experts rate the competitiveness of the domestic digital health industry at 5.4 points (9 points perfect) when compared to the world’s highest level (60 points when converted to 100 points), and telehealth care is the lowest with 4.1 points.
In order to increase the competitiveness of the domestic digital health industry, the improvement of related legal systems such as health insurance fee application and registration process, R&D, clinical trial, commercialization connection infrastructure, and medical device licensing and other related legal systems were suggested.
According to market research firm GIA, the global digital health industry is expected to show a significant growth rate (18.8%) from $152 billion in 2020 to $50.8 billion in 2027. This is 35% of the global semiconductor market of $433 billion.
By sector, the mobile health industry accounts for more than half, accounting for 57% ($86 billion) of the total, and telehealth care is small with 4% of the total, but the growth rate is projected to be the highest at 30.9%.
According to the report, experts generally agreed with the global industry outlook (8.3 points/9 points out), but predicted that the domestic outlook moves somewhat differently than the world (4.9 points/9 points out). For this reason, it was suggested that domestic laws and institutions are not set in the direction of revitalizing the industry.
As a result of examining the current state of policy support in the domestic digital health industry, focusing on national research and development (R&D), a total of 2324 billion won in medical information and system research expenses from 2016 to 2018. By field, u-Health service-related technologies 81.3 billion won (35%), hospital medical systems and facilities 47.5 billion won (20%), remote and home medical care 16.8 billion won (7%), medical information standardization 15.9 billion won (7) %), medical information security of 8.9 billion won (4%), medical knowledge expression of 2.6 billion won (1%).
The growth rate of research expenditures by field was 59% for hospital medical systems and facilities, 21% for standardization of medical information, 58% for medical information security, and 24% for remote and home medical care. In the case of the system, it is analyzed because of the structural factors in which the infrastructure construction and information standardization work must be preceded.
Experts evaluated the need to expand R&D research expenses in the fields of medical information security and medical information standardization somewhat higher than in other fields, and that in order to increase the effectiveness of the R&D business in the domestic digital health field, it is necessary to focus on the policy to support commercialization of R&D-developed technologies. Advised.
Through this study, KISA should calculate the size and prospect of the domestic industry through the establishment and status survey of the domestic digital health industry, and measures to increase domestic industrial competitiveness and effects in the digital health field (cost reduction, clinical effect, patient acceptance, etc.) ), and the need for evaluation support.